Key Record Dates
ClinicalTrials.gov Identifier: | NCT03235544 |
---|---|
Brief Title: | A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor ((CITADEL-205)) |
First Submitted : | July 27, 2017 |
First Submitted that Met QC Criteria : | July 27, 2017 |
First Posted : | August 1, 2017 |
Results First Submitted : | January 14, 2022 |
Results First Submitted that Met QC Criteria : | January 14, 2022 |
Results First Posted : | February 10, 2022 |
Last Update Submitted that Met QC Criteria : | November 14, 2023 |
Last Update Posted : | November 18, 2023 |